These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 26550166

  • 1. Lack of association between interleukin-2 (IL-2) gene rs2069762 polymorphism and cancer risk: a meta-analysis.
    Wang Y, Shu Y, Jiang H, Sun B, Ma Z, Tang W.
    Int J Clin Exp Med; 2015; 8(8):12557-65. PubMed ID: 26550166
    [Abstract] [Full Text] [Related]

  • 2. Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis.
    Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C.
    Onco Targets Ther; 2016; 9():2181-92. PubMed ID: 27143914
    [Abstract] [Full Text] [Related]

  • 3. IL-2 -330T/G polymorphism and cancer risk: a meta-analysis.
    Zhao H, Wang R.
    Onco Targets Ther; 2015; 8():1753-60. PubMed ID: 26229483
    [Abstract] [Full Text] [Related]

  • 4. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis.
    Mao X, Ke Z, Liu S, Tang B, Wang J, Huang H, Chen S.
    Gene; 2015 Nov 15; 573(1):75-83. PubMed ID: 26169021
    [Abstract] [Full Text] [Related]

  • 5. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW, Li JC, Zhang M, Wang JZ, Li BH, Liu Y, Liao SQ, Zhang MJ, Gao CY, Zhang LL.
    Gene; 2013 Oct 15; 529(1):94-103. PubMed ID: 23954871
    [Abstract] [Full Text] [Related]

  • 6. IL-13 -1112 polymorphism and periodontitis susceptibility: a meta-analysis.
    Zhang W, Xu P, Chen Z, Cheng Y, Li X, Mao Q.
    BMC Oral Health; 2018 Feb 07; 18(1):21. PubMed ID: 29415708
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between interleukin-10-819T/C polymorphism and risk of ischemic stroke: A meta-analysis.
    Zuo S, Zheng T, Li H.
    Medicine (Baltimore); 2020 May 07; 99(20):e19808. PubMed ID: 32443287
    [Abstract] [Full Text] [Related]

  • 12. Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk.
    Geng P, Ou J, Xie G, Li J, Zhao X, Xiang L, Liao Y, Wang N, Liang H.
    Medicine (Baltimore); 2015 Nov 07; 94(44):e0938. PubMed ID: 26554761
    [Abstract] [Full Text] [Related]

  • 13. IL-10 -1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis.
    Liu L, Zheng F.
    Onco Targets Ther; 2016 Nov 07; 9():6083-6091. PubMed ID: 27785055
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls.
    Zhu B, Xiao C, Zhu B, Zheng Z, Liang J.
    Int J Clin Exp Med; 2015 Nov 07; 8(8):14335-44. PubMed ID: 26550419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer.
    Yang Y, Wang W, Zhang L, Zhang S, Liu G, Yu Y, Liao M.
    Oncotarget; 2016 May 03; 7(18):25528-34. PubMed ID: 27009866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y, Shi J, Qiu S, Qiao Y, Zhang X, Cheng Y, Liu Y.
    BMC Cancer; 2018 Nov 01; 18(1):1060. PubMed ID: 30384829
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.